[Drug therapy of patent ductus arteriosus in premature and newborn infants].
D001049:Apnea / Q000209:etiology; D001241:Aspirin / Q000627:therapeutic use; D002738:Chloroquine / Q000627:therapeutic use; D004071:Digitalis Glycosides / Q000627:therapeutic use; D004374:Ductus Arteriosus, Patent / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy*; D006801:Humans; D007213:Indomethacin / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases / Q000188:drug therapy*; D007234:Infant, Premature; D007235:Infant, Premature, Diseases / Q000188:drug therapy*
D004071:Digitalis Glycosides; D002738:Chloroquine; D001241:Aspirin; D007213:Indomethacin
Die medikamentöse Behandlung des Ductus arteriosus persistens bei Früh- und Neugeborenen.